TCG Crossover GP II, LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-16 4:37 pm Purchase |
2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
TCG Crossover GP II, LLC | 2,702,157 9.900% |
2,702,157 (New Position) |
Filing |